Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach

Abstract Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient’s invitation to participate and then agreement or refusal to participate. Objectives The stud...

Full description

Saved in:
Bibliographic Details
Published in:Age and ageing Vol. 53; no. 2
Main Authors: Hagège, Meoïn, Bringuier, Michaël, Martinez-Tapia, Claudia, Chouaïd, Christos, Helissey, Carole, Brain, Etienne, Lempdes, Godelieve Rochette, Dubot, Coraline, Bello-Roufai, Diana, Geiss, Romain, Kempf, Emmanuelle, Gourden, Audrey, Elgharbi, Hanane, Garrigou, Sonia, Gregoire, Laetitia, Derbez, Benjamin, Canouï-Poitrine, Florence
Format: Journal Article
Language:English
Published: England Oxford University Press 01-02-2024
Oxford Publishing Limited (England)
Oxford University Press (OUP)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient’s invitation to participate and then agreement or refusal to participate. Objectives The study’s primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients’ and professionals’ perspectives. Methods Here, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France. Results We found that non-invitation and low CT participation are mainly related to the patients’ sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals’ perceptions of insufficient informal support or a high homecare requirement. Conclusion Our results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician–patient relationship, the medical profession and hospital funding, rather than the patient alone.
AbstractList Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient's invitation to participate and then agreement or refusal to participate.BACKGROUNDFew studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient's invitation to participate and then agreement or refusal to participate.The study's primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients' and professionals' perspectives.OBJECTIVESThe study's primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients' and professionals' perspectives.Here, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France.METHODSHere, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France.We found that non-invitation and low CT participation are mainly related to the patients' sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals' perceptions of insufficient informal support or a high homecare requirement.RESULTSWe found that non-invitation and low CT participation are mainly related to the patients' sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals' perceptions of insufficient informal support or a high homecare requirement.Our results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician-patient relationship, the medical profession and hospital funding, rather than the patient alone.CONCLUSIONOur results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician-patient relationship, the medical profession and hospital funding, rather than the patient alone.
Abstract Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient’s invitation to participate and then agreement or refusal to participate. Objectives The study’s primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients’ and professionals’ perspectives. Methods Here, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France. Results We found that non-invitation and low CT participation are mainly related to the patients’ sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals’ perceptions of insufficient informal support or a high homecare requirement. Conclusion Our results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician–patient relationship, the medical profession and hospital funding, rather than the patient alone.
Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient's invitation to participate and then agreement or refusal to participate. The study's primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients' and professionals' perspectives. Here, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France. We found that non-invitation and low CT participation are mainly related to the patients' sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals' perceptions of insufficient informal support or a high homecare requirement. Our results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician-patient relationship, the medical profession and hospital funding, rather than the patient alone.
Abstract Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient’s invitation to participate and then agreement or refusal to participate. Objectives The study’s primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients’ and professionals’ perspectives. Methods Here, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France. Results We found that non-invitation and low CT participation are mainly related to the patients’ sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals’ perceptions of insufficient informal support or a high homecare requirement. Conclusion Our results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician–patient relationship, the medical profession and hospital funding, rather than the patient alone.
Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient’s invitation to participate and then agreement or refusal to participate. Objectives The study’s primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients’ and professionals’ perspectives. Methods Here, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France. Results We found that non-invitation and low CT participation are mainly related to the patients’ sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals’ perceptions of insufficient informal support or a high homecare requirement. Conclusion Our results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician–patient relationship, the medical profession and hospital funding, rather than the patient alone.
Author Brain, Etienne
Garrigou, Sonia
Bringuier, Michaël
Elgharbi, Hanane
Gregoire, Laetitia
Helissey, Carole
Gourden, Audrey
Lempdes, Godelieve Rochette
Dubot, Coraline
Martinez-Tapia, Claudia
Derbez, Benjamin
Chouaïd, Christos
Geiss, Romain
Kempf, Emmanuelle
Canouï-Poitrine, Florence
Hagège, Meoïn
Bello-Roufai, Diana
Author_xml – sequence: 1
  givenname: Meoïn
  orcidid: 0000-0002-5863-8870
  surname: Hagège
  fullname: Hagège, Meoïn
  email: hagege@inserm.fr
– sequence: 2
  givenname: Michaël
  orcidid: 0000-0002-7643-2956
  surname: Bringuier
  fullname: Bringuier, Michaël
  email: michael.bringuier@curie.fr
– sequence: 3
  givenname: Claudia
  surname: Martinez-Tapia
  fullname: Martinez-Tapia, Claudia
  email: claudia.tapia-ext@aphp.fr
– sequence: 4
  givenname: Christos
  surname: Chouaïd
  fullname: Chouaïd, Christos
  email: Christos.Chouaid@chicreteil.fr
– sequence: 5
  givenname: Carole
  surname: Helissey
  fullname: Helissey, Carole
  email: carole.helissey@gmail.com
– sequence: 6
  givenname: Etienne
  surname: Brain
  fullname: Brain, Etienne
  email: etienne.brain@curie.fr
– sequence: 7
  givenname: Godelieve Rochette
  surname: Lempdes
  fullname: Lempdes, Godelieve Rochette
  email: godelieve.delempdes@curie.fr
– sequence: 8
  givenname: Coraline
  surname: Dubot
  fullname: Dubot, Coraline
  email: coraline.dubot@curie.fr
– sequence: 9
  givenname: Diana
  surname: Bello-Roufai
  fullname: Bello-Roufai, Diana
  email: diana.bello-roufai@curie.fr
– sequence: 10
  givenname: Romain
  surname: Geiss
  fullname: Geiss, Romain
  email: geiss.romain@gmail.com
– sequence: 11
  givenname: Emmanuelle
  surname: Kempf
  fullname: Kempf, Emmanuelle
  email: emmanuelle.kempf@aphp.fr
– sequence: 12
  givenname: Audrey
  surname: Gourden
  fullname: Gourden, Audrey
  email: audrey.gourden@gmail.com
– sequence: 13
  givenname: Hanane
  surname: Elgharbi
  fullname: Elgharbi, Hanane
  email: Hanane.ElGharbi@chicreteil.fr
– sequence: 14
  givenname: Sonia
  surname: Garrigou
  fullname: Garrigou, Sonia
  email: sonia.garrigou@curie.fr
– sequence: 15
  givenname: Laetitia
  surname: Gregoire
  fullname: Gregoire, Laetitia
  email: laetitia.gregoire@aphp.fr
– sequence: 16
  givenname: Benjamin
  surname: Derbez
  fullname: Derbez, Benjamin
  email: Benjamin.derbez@univ-paris8.fr
– sequence: 17
  givenname: Florence
  surname: Canouï-Poitrine
  fullname: Canouï-Poitrine, Florence
  email: florence.canoui-poitrine@aphp.fr
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38346934$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04604592$$DView record in HAL
BookMark eNqFkk9vFCEYxompsdvq1aMh8aKHafkzDDNemqZVa7KJFz0TFt7doZmBEZjqfgE_d1l3rdqLJwLP733gIc8JOvLBA0IvKTmjpOPnegPOb871WgMh8gla0LppK9by-ggtCCGsIpJ1x-gkpduypYKyZ-iYF73peL1AP69dAp-13wzFB-cecASdgk_4e7_FYbAQsbbzkBO2AfuQd7p1wxZPOmZn3KQzYOex0d4UNkenh_QOa5yCcaGCyVkYXRjCxhk94NH9AItHyH2wCetpikGb_jl6ui5j8OKwnqKvH95_ubqplp8_frq6XFambmWuVrbRUhBBibTCcglGSM0kYxbWkpO65JOUSbEC1ja6FqZtgBpiGg4rQjjwU3Sx953m1QjWlOhRD2qKbtRxq4J26l_Fu15twp2ipG0ob0RxeLt36B_N3Vwu1e6M1A2pRcfuaGHfHG6L4dsMKavRJQPDoD2EOSnWsYbIrm1lQV8_Qm_DHH35i0IJwVld_6LO9pSJIaUI64cXUKJ2fVD7PqhDH8rAq7_zPuC_C_AnTpin_5ndA4XxxL4
CitedBy_id crossref_primary_10_1093_ageing_afae019
Cites_doi 10.1002/cncr.33991
10.1200/JCO.2015.63.0319
10.1016/j.jgo.2021.03.002
10.1016/j.arr.2021.101455
10.3322/caac.21638
10.1200/JCO.2013.55.0418
10.1634/theoncologist.2019-0166
10.1016/j.esmoop.2022.100468
10.1001/jamaoncol.2019.2055
10.1136/bmjoq-2022-002044
10.1056/NEJM198405243102106
10.1016/j.jgo.2019.07.017
10.1200/JCO.2012.45.0999
10.1684/sss.2022.0223
10.1080/02841860600911164
10.1001/jama.297.11.1233
10.1136/bmjmed-2022-000395
10.3390/curroncol29050253
ContentType Journal Article
Copyright The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society. 2024
The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society. 2024
– notice: The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID TOX
NPM
AAYXX
CITATION
7QJ
7T5
7TK
7U9
H94
K9.
NAPCQ
7X8
1XC
BXJBU
IHQJB
VOOES
5PM
DOI 10.1093/ageing/afae007
DatabaseName Open Access: Oxford University Press Open Journals
PubMed
CrossRef
Applied Social Sciences Index & Abstracts (ASSIA)
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Hyper Article en Ligne (HAL)
HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société
HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société (Open Access)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Nursing & Allied Health Premium
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Applied Social Sciences Index and Abstracts (ASSIA)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

Nursing & Allied Health Premium
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2834
ExternalDocumentID oai_HAL_hal_04604592v1
10_1093_ageing_afae007
38346934
10.1093/ageing/afae007
Genre Journal Article
GrantInformation_xml – fundername: Mondor Hospital, Créteil, France
  grantid: 00011558
– fundername: INCa
  grantid: SHS-ESP 2015
– fundername: ;
  grantid: SHS-ESP 2015; NI15022
– fundername: ;
  grantid: 00011558
GroupedDBID ---
-E4
-~X
..I
.2P
.GJ
.I3
.ZR
04C
0R~
1TH
23M
2WC
354
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
6J9
70D
8GL
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
ABEHJ
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABPTD
ABQLI
ABQNK
ABQTQ
ABSAR
ABSMQ
ABWST
ABXVV
ABZBJ
ACBNA
ACFRR
ACGFO
ACGFS
ACMRT
ACNCT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ACZBC
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFSHK
AFXAL
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AI.
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BKOMP
BMSDO
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBD
EBS
EE~
EIHBH
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FAC
FAS
FECEO
FEDTE
FJW
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GICCO
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
H~9
IAO
IEA
IHR
INH
INR
IOF
IOX
ITC
J21
J5H
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
LPU
M-Z
M49
MBLQV
MHKGH
N9A
NGC
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RHF
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TCURE
TEORI
TJX
TMA
TOX
TR2
VH1
VVN
W8F
WH7
WOQ
WOW
X7H
YAYTL
YCJ
YKOAZ
YXANX
ZGI
ZKX
ZXP
~91
ABEJV
NPM
AAYXX
CITATION
7QJ
7T5
7TK
7U9
H94
K9.
NAPCQ
7X8
1XC
BXJBU
IHQJB
VOOES
5PM
ID FETCH-LOGICAL-c487t-bd6a7505107d5d37ec57a2722def730401571275be286a45c86e1c0c63eb003e3
ISSN 0002-0729
1468-2834
IngestDate Tue Sep 17 21:29:53 EDT 2024
Tue Oct 15 16:00:18 EDT 2024
Sat Oct 26 04:48:15 EDT 2024
Thu Nov 21 04:20:36 EST 2024
Thu Nov 21 21:22:43 EST 2024
Sat Nov 02 12:27:04 EDT 2024
Wed Aug 28 03:16:05 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords participation
inclusion
older people
refusal to participate
non-invitation
cancer trial
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c487t-bd6a7505107d5d37ec57a2722def730401571275be286a45c86e1c0c63eb003e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC10861365
Benjamin Derbez and Florence Canouï-Poitrine contributed equally.
ORCID 0000-0002-5863-8870
0000-0002-7643-2956
0000-0002-2817-7866
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC10861365
PMID 38346934
PQID 2955324487
PQPubID 36083
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10861365
hal_primary_oai_HAL_hal_04604592v1
proquest_miscellaneous_2926079887
proquest_journals_2955324487
crossref_primary_10_1093_ageing_afae007
pubmed_primary_38346934
oup_primary_10_1093_ageing_afae007
PublicationCentury 2000
PublicationDate 2024-02-01
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-02-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Age and ageing
PublicationTitleAlternate Age Ageing
PublicationYear 2024
Publisher Oxford University Press
Oxford Publishing Limited (England)
Oxford University Press (OUP)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
– name: Oxford University Press (OUP)
References Weber (2024031313363247800_ref15) 1949
European Medicines Agency (2024031313363247800_ref2) 2006
Ousseine (2024031313363247800_ref24) 2022; 29
Mohd Noor (2024031313363247800_ref16) 2013; 31
Javier-DesLoges (2024031313363247800_ref3) 2022; 128
Tracy (2024031313363247800_ref14) 2013
Baldini (2024031313363247800_ref8) 2022; 7
Sedrak (2024031313363247800_ref22) 2021; 71
Varma (2024031313363247800_ref25) 2023; 2
Institut National du Cancer (2024031313363247800_ref7) 2022
Gouveia (2024031313363247800_ref17) 2022; 11
Hurria (2024031313363247800_ref4) 2014; 32
Canoui-Poitrine (2024031313363247800_ref9) 2019; 24
Food and Drug Administration (2024031313363247800_ref1) 2022
Derbez (2024031313363247800_ref21) 2022; 40
Sedrak (2024031313363247800_ref23) 2020; 11
Hurria (2024031313363247800_ref12) 2007
Hagège (2024031313363247800_ref20) 2021; 12
Ludmir (2024031313363247800_ref5) 2019; 5
Madsen (2024031313363247800_ref18) 2007; 46
Km (2024031313363247800_ref19) 1984; 310
Veronese (2024031313363247800_ref6) 2021; 71
Charmaz (2024031313363247800_ref13) 2014
Spall (2024031313363247800_ref11) 2007; 297
Hurria (2024031313363247800_ref10) 2015; 33
References_xml – volume: 128
  start-page: 770
  year: 2022
  ident: 2024031313363247800_ref3
  article-title: Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials
  publication-title: Cancer
  doi: 10.1002/cncr.33991
  contributor:
    fullname: Javier-DesLoges
– volume-title: Constructing Grounded Theory
  year: 2014
  ident: 2024031313363247800_ref13
  contributor:
    fullname: Charmaz
– volume: 33
  start-page: 3826
  year: 2015
  ident: 2024031313363247800_ref10
  article-title: Improving the evidence base for treating older adults with cancer: American Society of Clinical Oncology Statement
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.63.0319
  contributor:
    fullname: Hurria
– volume: 12
  start-page: 945
  year: 2021
  ident: 2024031313363247800_ref20
  article-title: Including older patients in cancer trials: a qualitative study of collaboration between geriatricians and oncologists
  publication-title: J Geriatr Oncol
  doi: 10.1016/j.jgo.2021.03.002
  contributor:
    fullname: Hagège
– volume-title: Inclusion des Patients Dans les Essais Cliniques En Cancérologie : L’enquête Annuelle de l’Institut National Du Cancer
  year: 2022
  ident: 2024031313363247800_ref7
  contributor:
    fullname: Institut National du Cancer
– volume-title: Qualitative Research Methods: Collecting Evidence, Crafting Analysis, Communicating Impact
  year: 2013
  ident: 2024031313363247800_ref14
  contributor:
    fullname: Tracy
– start-page: 49
  year: 1949
  ident: 2024031313363247800_ref15
  contributor:
    fullname: Weber
– volume: 71
  start-page: 101455
  year: 2021
  ident: 2024031313363247800_ref6
  article-title: Underrepresentation of older adults in clinical trials on COVID-19 vaccines: a systematic review
  publication-title: Ageing Res Rev
  doi: 10.1016/j.arr.2021.101455
  contributor:
    fullname: Veronese
– start-page: 10
  volume-title: Inclusion of Older Adults in Cancer Clinical Trials
  year: 2022
  ident: 2024031313363247800_ref1
  contributor:
    fullname: Food and Drug Administration
– volume: 71
  start-page: 78
  year: 2021
  ident: 2024031313363247800_ref22
  article-title: Older adult participation in cancer clinical trials: a systematic review of barriers and interventions
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21638
  contributor:
    fullname: Sedrak
– volume: 32
  start-page: 2587
  year: 2014
  ident: 2024031313363247800_ref4
  article-title: Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2013.55.0418
  contributor:
    fullname: Hurria
– volume: 24
  start-page: e1351
  year: 2019
  ident: 2024031313363247800_ref9
  article-title: Inclusion of older patients with cancer in clinical trials: The SAGE Prospective Multicenter Cohort Survey
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2019-0166
  contributor:
    fullname: Canoui-Poitrine
– volume: 7
  start-page: 100468
  year: 2022
  ident: 2024031313363247800_ref8
  article-title: Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
  publication-title: ESMO Open
  doi: 10.1016/j.esmoop.2022.100468
  contributor:
    fullname: Baldini
– volume: 5
  start-page: 1769
  year: 2019
  ident: 2024031313363247800_ref5
  article-title: Factors associated with age disparities among cancer clinical trial participants
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2019.2055
  contributor:
    fullname: Ludmir
– start-page: 351
  volume-title: Clinical Trials in Older Adults with Cancer: Past and Future. Oncology
  year: 2007
  ident: 2024031313363247800_ref12
  contributor:
    fullname: Hurria
– volume: 11
  start-page: e002044
  year: 2022
  ident: 2024031313363247800_ref17
  article-title: Sociodemographic and psychological characteristics influencing patients’ willingness to participate in clinical trials
  publication-title: BMJ Open Qual
  doi: 10.1136/bmjoq-2022-002044
  contributor:
    fullname: Gouveia
– volume: 310
  start-page: 1363
  year: 1984
  ident: 2024031313363247800_ref19
  article-title: Physicians’ reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198405243102106
  contributor:
    fullname: Km
– volume: 11
  start-page: 327
  year: 2020
  ident: 2024031313363247800_ref23
  article-title: Barriers to clinical trial enrollment of older adults with cancer: a qualitative study of the perceptions of community and academic oncologists
  publication-title: J Geriatr Oncol
  doi: 10.1016/j.jgo.2019.07.017
  contributor:
    fullname: Sedrak
– volume: 31
  start-page: 224
  year: 2013
  ident: 2024031313363247800_ref16
  article-title: Effect of patient socioeconomic status on access to early-phase cancer trials
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.45.0999
  contributor:
    fullname: Mohd Noor
– volume: 40
  start-page: 5
  year: 2022
  ident: 2024031313363247800_ref21
  article-title: « Est-ce que tu ferais ça à ta mère ? » Délibération, standardisation et décision médicale en réunion de concertation pluridisciplinaire de cancérologie
  publication-title: Sciences sociales et santé
  doi: 10.1684/sss.2022.0223
  contributor:
    fullname: Derbez
– volume: 46
  start-page: 49
  year: 2007
  ident: 2024031313363247800_ref18
  article-title: Participating in a cancer clinical trial? The balancing of options in the loneliness of autonomy: a grounded theory interview study
  publication-title: Acta Oncol
  doi: 10.1080/02841860600911164
  contributor:
    fullname: Madsen
– volume: 297
  start-page: 1233
  year: 2007
  ident: 2024031313363247800_ref11
  article-title: Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review
  publication-title: JAMA
  doi: 10.1001/jama.297.11.1233
  contributor:
    fullname: Spall
– volume: 2
  start-page: e000395
  year: 2023
  ident: 2024031313363247800_ref25
  article-title: Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study
  publication-title: BMJ Med
  doi: 10.1136/bmjmed-2022-000395
  contributor:
    fullname: Varma
– volume: 29
  start-page: 3118
  year: 2022
  ident: 2024031313363247800_ref24
  article-title: Health literacy and clinical trial participation in Frenchcancer patients: a National Survey
  publication-title: Curr Oncol
  doi: 10.3390/curroncol29050253
  contributor:
    fullname: Ousseine
– volume-title: Adequacy of Guidance on the Elderly Regarding Medicinal Products for Human Use
  year: 2006
  ident: 2024031313363247800_ref2
  contributor:
    fullname: European Medicines Agency
SSID ssj0001512
Score 2.4710891
Snippet Abstract Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial...
Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a...
Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being...
Abstract Background Few studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial...
SourceID pubmedcentral
hal
proquest
crossref
pubmed
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
SubjectTerms Cancer
Clinical research
Clinical trials
Epidemiology
Geriatry and gerontology
Health care
Human health and pathology
Humanities and Social Sciences
Life Sciences
Living conditions
Medical personnel
Mixed methods research
Older people
Participation
Patients
Refusal
Relatives
Research Paper
Santé publique et épidémiologie
Social interactions
Social isolation
Sociodemographics
Sociology
Title Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach
URI https://www.ncbi.nlm.nih.gov/pubmed/38346934
https://www.proquest.com/docview/2955324487
https://www.proquest.com/docview/2926079887
https://hal.science/hal-04604592
https://pubmed.ncbi.nlm.nih.gov/PMC10861365
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELbaRUJcEG-6LMggJA5VtKmdJ7fubqsiHheKxC1yEncbCZLVtlkeP4DfzYzHSZuqiOXAJUodJ00zX8ce55tvGHupwR2qOIwdEanA8cA3OmrkaidNFyKIXKmFkcyffQw_fI7OJt6k12uKr27a_quloQ1sjZmz_2Dt9qLQAPtgc9iC1WF7LbufFSadCLNzbSIU0s6REPNt-WNYYVFuEt1YDfNqWFZrPJ6bRQ7VUKyNkEiGeLgcmrIeK8qJRktWjt4UlTUW_lp8h1krlaJetSLl27Pe8Tm9pADf1YyUxumdm9f0ka3urivzcdrC9QTXHOuCQGX4_abDyYbKaDQQ9E9nri6I9Hv6RdV5sWEfLauaTprmW1IKnbUO4TX06CYy3p9DuePfUQudRjdy6ZhbJpolU-vzSaDYYlvsHUpIZoseDO4slHapQO-OQPefO_fZDQH-z0T6b962EwScZDVRGd5sqyUqj-kKx_b8zlypv0SmbicLcysY2uX0bk2S5nfYbRvd8DHB8i7r6fIeu_ne8jfus18ddHJAJ7fo5IBObtDJCZ08rzigk1t08i108qLkhE5O6HzNFd-LTW6wyS02eYPNB-zTdDI_nTm2EoiTQUC9dtI8UDC1hfEjzP1chjrzQyVCIXK9gCHKg0caYqWCFFxLoDw_iwI9ytwskFgaS2r5kB2UVakfMz6ScjFKVR67ceoppaNskWZhAL7MhaHekwP2qnnmyQUJviRE1JAJWSex1hmwF2CSthPqtM_G7xJsQ7aB58fiagSdwGJ_vdJRY9DEupJVImLfh2gHfv-APW8Pg_PHN3qq1FWNfUTgouIg9HlE9m-_SgLkg1h6AxZ1kNG54e6RslgagXmsvob018Pr3PwTdmvzVz1iB-vLWj9l_VVePzOw_w3DG_BF
link.rule.ids 230,315,782,786,887,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Disentangling+the+reasons+why+older+adults+do+not+readily+participate+in+cancer+trials%3A+a+socio-epidemiological+mixed+methods+approach&rft.jtitle=Age+and+ageing&rft.au=Hag%C3%A8ge%2C+Meo%C3%AFn&rft.au=Bringuier%2C+Micha%C3%ABl&rft.au=Martinez-Tapia%2C+Claudia&rft.au=Choua%C3%AFd%2C+Christos&rft.date=2024-02-01&rft.pub=Oxford+University+Press&rft.issn=0002-0729&rft.eissn=1468-2834&rft.volume=53&rft.issue=2&rft_id=info:doi/10.1093%2Fageing%2Fafae007&rft.externalDocID=10.1093%2Fageing%2Fafae007
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-0729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-0729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-0729&client=summon